224 related articles for article (PubMed ID: 27489022)
1. Premedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model.
Harada T; Ishimatsu Y; Hara A; Morita T; Nakashima S; Kakugawa T; Sakamoto N; Kosai K; Izumikawa K; Yanagihara K; Mukae H; Kohno S
J Pharmacol Exp Ther; 2016 Sep; 358(3):457-63. PubMed ID: 27489022
[TBL] [Abstract][Full Text] [Related]
2. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
[TBL] [Abstract][Full Text] [Related]
3. Halothane modulates the type i interferon response to influenza and minimizes the risk of secondary bacterial pneumonia through maintenance of neutrophil recruitment in an animal model.
MacDonald BA; Chakravarthy KV; Davidson BA; Mullan BA; Alluri R; Hakansson AP; Knight PR
Anesthesiology; 2015 Sep; 123(3):590-602. PubMed ID: 26120770
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
[TBL] [Abstract][Full Text] [Related]
5. Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model.
Wang H; Anthony D; Yatmaz S; Wijburg O; Satzke C; Levy B; Vlahos R; Bozinovski S
Clin Sci (Lond); 2017 Sep; 131(18):2347-2362. PubMed ID: 28779028
[TBL] [Abstract][Full Text] [Related]
6. Clarithromycin expands CD11b+Gr-1+ cells via the STAT3/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia.
Namkoong H; Ishii M; Fujii H; Yagi K; Asami T; Asakura T; Suzuki S; Hegab AE; Kamata H; Tasaka S; Atarashi K; Nakamoto N; Iwata S; Honda K; Kanai T; Hasegawa N; Koyasu S; Betsuyaku T
PLoS Pathog; 2018 Apr; 14(4):e1006955. PubMed ID: 29621339
[TBL] [Abstract][Full Text] [Related]
7. Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses.
Kash JC; Walters KA; Davis AS; Sandouk A; Schwartzman LM; Jagger BW; Chertow DS; Li Q; Kuestner RE; Ozinsky A; Taubenberger JK
mBio; 2011; 2(5):. PubMed ID: 21933918
[TBL] [Abstract][Full Text] [Related]
8. Allergic inflammation alters the lung microbiome and hinders synergistic co-infection with H1N1 influenza virus and Streptococcus pneumoniae in C57BL/6 mice.
LeMessurier KS; Iverson AR; Chang TC; Palipane M; Vogel P; Rosch JW; Samarasinghe AE
Sci Rep; 2019 Dec; 9(1):19360. PubMed ID: 31852944
[TBL] [Abstract][Full Text] [Related]
9. Influenza "Trains" the Host for Enhanced Susceptibility to Secondary Bacterial Infection.
Shirey KA; Perkins DJ; Lai W; Zhang W; Fernando LR; Gusovsky F; Blanco JCG; Vogel SN
mBio; 2019 May; 10(3):. PubMed ID: 31064834
[TBL] [Abstract][Full Text] [Related]
10. Leucomycin A3, a 16-membered macrolide antibiotic, inhibits influenza A virus infection and disease progression.
Sugamata R; Sugawara A; Nagao T; Suzuki K; Hirose T; Yamamoto K; Oshima M; Kobayashi K; Sunazuka T; Akagawa KS; Ōmura S; Nakayama T; Suzuki K
J Antibiot (Tokyo); 2014 Mar; 67(3):213-22. PubMed ID: 24496145
[TBL] [Abstract][Full Text] [Related]
11. The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.
Tanaka A; Nakamura S; Seki M; Iwanaga N; Kajihara T; Kitano M; Homma T; Kurihara S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
Antivir Ther; 2015; 20(1):11-9. PubMed ID: 24517996
[TBL] [Abstract][Full Text] [Related]
12. Influenza virus infection causes neutrophil dysfunction through reduced G-CSF production and an increased risk of secondary bacteria infection in the lung.
Ishikawa H; Fukui T; Ino S; Sasaki H; Awano N; Kohda C; Tanaka K
Virology; 2016 Dec; 499():23-29. PubMed ID: 27632562
[TBL] [Abstract][Full Text] [Related]
13. Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.
Wu Y; Tu W; Lam KT; Chow KH; Ho PL; Guan Y; Peiris JS; Lau YL
J Virol; 2015 Feb; 89(4):2013-23. PubMed ID: 25428873
[TBL] [Abstract][Full Text] [Related]
14. Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 Virus.
Fukushi M; Yamashita M; Miyoshi-Akiyama T; Kubo S; Yamamoto K; Kudo K
PLoS One; 2012; 7(8):e42419. PubMed ID: 22879974
[TBL] [Abstract][Full Text] [Related]
15. A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice.
Karlsson EA; Meliopoulos VA; van de Velde NC; van de Velde LA; Mann B; Gao G; Rosch J; Tuomanen E; McCullers J; Vogel P; Schultz-Cherry S
mBio; 2017 Sep; 8(5):. PubMed ID: 28928207
[TBL] [Abstract][Full Text] [Related]
16. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection.
van der Sluijs KF; van Elden LJ; Nijhuis M; Schuurman R; Pater JM; Florquin S; Goldman M; Jansen HM; Lutter R; van der Poll T
J Immunol; 2004 Jun; 172(12):7603-9. PubMed ID: 15187140
[TBL] [Abstract][Full Text] [Related]
17. Impact of endogenous protein C on pulmonary coagulation and injury during lethal H1N1 influenza in mice.
Schouten M; de Boer JD; van der Sluijs KF; Roelofs JJ; van't Veer C; Levi M; Esmon CT; van der Poll T
Am J Respir Cell Mol Biol; 2011 Oct; 45(4):789-94. PubMed ID: 21330465
[TBL] [Abstract][Full Text] [Related]
18. Clarithromycin prevents smoke-induced emphysema in mice.
Nakanishi Y; Kobayashi D; Asano Y; Sakurai T; Kashimura M; Okuyama S; Yoneda Y; Shapiro SD; Takayama K
Am J Respir Crit Care Med; 2009 Feb; 179(4):271-8. PubMed ID: 19060231
[TBL] [Abstract][Full Text] [Related]
19. [Umifenovir (Arbidol) efficacy in experimental mixed viral and bacterial pneumonia of mice].
Leneva IA; Falynskova IN; Leonova EI; Fedyakina IT; Makhmudova NR; Osipova EA; Lepekha LN; Mikhailova NA; Zverev VV
Antibiot Khimioter; 2014; 59(9-10):17-24. PubMed ID: 25975111
[TBL] [Abstract][Full Text] [Related]
20. The role of IL-27 in susceptibility to post-influenza Staphylococcus aureus pneumonia.
Robinson KM; Lee B; Scheller EV; Mandalapu S; Enelow RI; Kolls JK; Alcorn JF
Respir Res; 2015 Feb; 16(1):10. PubMed ID: 25651926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
